首页> 外文期刊>Pathology International >Molecular pathogenesis of human amyloidosis: Lessons from (2)-microglobulin-related amyloidosis
【24h】

Molecular pathogenesis of human amyloidosis: Lessons from (2)-microglobulin-related amyloidosis

机译:人类淀粉样变性的分子发病机制:(2)-微球蛋白相关淀粉样变性的教训

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Amyloidosis refers to a group of diseases with amyloid fibrils deposited in various organs and is classified into more than 30 diseases in humans based on the kind of amyloid protein. In order to elucidate the molecular pathogenesis of human amyloidosis, we studied the molecular mechanism of amyloid fibril formation in vitro. We first developed a novel fluorometric method to determine amyloid fibrils in vitro based on the unique characteristics of thioflavin T. We next proposed a nucleation-dependent polymerization model to explain the general mechanism of amyloid fibril formation in vitro. Based on this model, we characterized the biological molecular interactions that promote or inhibit amyloid fibril formation in vitro and developed models of pathological molecular environment for inducing human (2)-microglobulin-related amyloidosis in long-term hemodialysis patients. We also proposed a novel and attractive cytotoxic mechanism of (2)-microglobulin amyloid fibrils, that is, the disruption of endosomal/lysosomal membranes by endocytosed amyloid fibrils. These findings may be useful to elucidate the molecular pathogenesis of other kinds of human amyloidosis.
机译:淀粉样变性病是指一组淀粉样蛋白原纤维沉积在各种器官中的疾病,根据淀粉样蛋白的种类,人类可将其分类为30多种疾病。为了阐明人类淀粉样变性病的分子发病机理,我们研究了淀粉样蛋白原纤维形成的分子机制。我们首先开发了一种新的荧光方法,根据硫黄素T的独特特性在体外测定淀粉样蛋白原纤维。接下来,我们提出了成核依赖性的聚合模型来解释淀粉样蛋白原纤维在体外形成的一般机理。基于此模型,我们表征了在体外促进或抑制淀粉样蛋白原纤维形成的生物学分子相互作用,并开发了在长期血液透析患者中​​诱导人(2)-微球蛋白相关淀粉样变性的病理分子环境模型。我们还提出了一种新颖和有吸引力的(2)-微球蛋白淀粉样蛋白纤维的细胞毒性机制,即内吞的淀粉样蛋白纤维破坏内体/溶酶体膜。这些发现可能有助于阐明其他类型的人类淀粉样变性的分子发病机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号